Global Human Gene Therapy Supply, Demand and Key Producers, 2023-2029

Description

The global Human Gene Therapy market size is expected to reach $ 7778.9 million by 2029, rising at a market growth of 6.0% CAGR during the forecast period (2023-2029).

Advances in gene therapy technology, increasing understanding of genetics, and the potential for addressing previously untreatable diseases contribute to the growth of the Human Gene Therapy market.

Gene therapy is a medical approach that treats or prevents disease by correcting the underlying genetic problem. Gene therapy techniques allow doctors to treat a disorder by altering a person's genetic makeup instead of using drugs or surgery.

This report studies the global Human Gene Therapy production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Human Gene Therapy, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Human Gene Therapy that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Human Gene Therapy total production and demand, 2018-2029, (K Units)
Global Human Gene Therapy total production value, 2018-2029, (USD Million)
Global Human Gene Therapy production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Human Gene Therapy consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Human Gene Therapy domestic production, consumption, key domestic manufacturers and share
Global Human Gene Therapy production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Human Gene Therapy production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Human Gene Therapy production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).

This reports profiles key players in the global Human Gene Therapy market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Biogen, Sarepta Therapeutics, Gilead Sciences, Amgen, Novartis, Orchard Therapeutics, Spark Therapeutics, Agc Biologics and Anges, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Human Gene Therapy market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Human Gene Therapy Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Human Gene Therapy Market, Segmentation by Type
    Non-viral Vectors
    Viral Vectors

Global Human Gene Therapy Market, Segmentation by Application
    Neurological Diseases
    Cancer
    DMD (Duchenne Muscular Dystrophy)
    Hepatological Diseases
    Others

Companies Profiled:
    Biogen
    Sarepta Therapeutics
    Gilead Sciences
    Amgen
    Novartis
    Orchard Therapeutics
    Spark Therapeutics
    Agc Biologics
    Anges
    Bluebird Bio
    Jazz Pharmaceuticals
    Dynavax Technologies
    Human Stem Cells Institute
    Sibiono Genetech
    Shanghai Sunway Biotech
    Uniqure N.V.
    Gensight Biologics S.A.
    Celgene Corporation
    Cellectis
    Sangamo Therapeutics
    Mustang Bio
    AGTC
    Poseida Therapeutics

Key Questions Answered
1. How big is the global Human Gene Therapy market?
2. What is the demand of the global Human Gene Therapy market?
3. What is the year over year growth of the global Human Gene Therapy market?
4. What is the production and production value of the global Human Gene Therapy market?
5. Who are the key producers in the global Human Gene Therapy market?

Table of Contents

1 Supply Summary
    1.1 Human Gene Therapy Introduction
    1.2 World Human Gene Therapy Supply & Forecast
        1.2.1 World Human Gene Therapy Production Value (2018 & 2022 & 2029)
        1.2.2 World Human Gene Therapy Production (2018-2029)
        1.2.3 World Human Gene Therapy Pricing Trends (2018-2029)
    1.3 World Human Gene Therapy Production by Region (Based on Production Site)
        1.3.1 World Human Gene Therapy Production Value by Region (2018-2029)
        1.3.2 World Human Gene Therapy Production by Region (2018-2029)
        1.3.3 World Human Gene Therapy Average Price by Region (2018-2029)
        1.3.4 North America Human Gene Therapy Production (2018-2029)
        1.3.5 Europe Human Gene Therapy Production (2018-2029)
        1.3.6 China Human Gene Therapy Production (2018-2029)
        1.3.7 Japan Human Gene Therapy Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Human Gene Therapy Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Human Gene Therapy Major Market Trends

2 Demand Summary
    2.1 World Human Gene Therapy Demand (2018-2029)
    2.2 World Human Gene Therapy Consumption by Region
        2.2.1 World Human Gene Therapy Consumption by Region (2018-2023)
        2.2.2 World Human Gene Therapy Consumption Forecast by Region (2024-2029)
    2.3 United States Human Gene Therapy Consumption (2018-2029)
    2.4 China Human Gene Therapy Consumption (2018-2029)
    2.5 Europe Human Gene Therapy Consumption (2018-2029)
    2.6 Japan Human Gene Therapy Consumption (2018-2029)
    2.7 South Korea Human Gene Therapy Consumption (2018-2029)
    2.8 ASEAN Human Gene Therapy Consumption (2018-2029)
    2.9 India Human Gene Therapy Consumption (2018-2029)

3 World Human Gene Therapy Manufacturers Competitive Analysis
    3.1 World Human Gene Therapy Production Value by Manufacturer (2018-2023)
    3.2 World Human Gene Therapy Production by Manufacturer (2018-2023)
    3.3 World Human Gene Therapy Average Price by Manufacturer (2018-2023)
    3.4 Human Gene Therapy Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Human Gene Therapy Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Human Gene Therapy in 2022
        3.5.3 Global Concentration Ratios (CR8) for Human Gene Therapy in 2022
    3.6 Human Gene Therapy Market: Overall Company Footprint Analysis
        3.6.1 Human Gene Therapy Market: Region Footprint
        3.6.2 Human Gene Therapy Market: Company Product Type Footprint
        3.6.3 Human Gene Therapy Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Human Gene Therapy Production Value Comparison
        4.1.1 United States VS China: Human Gene Therapy Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Human Gene Therapy Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Human Gene Therapy Production Comparison
        4.2.1 United States VS China: Human Gene Therapy Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Human Gene Therapy Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Human Gene Therapy Consumption Comparison
        4.3.1 United States VS China: Human Gene Therapy Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Human Gene Therapy Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Human Gene Therapy Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Human Gene Therapy Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Human Gene Therapy Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Human Gene Therapy Production (2018-2023)
    4.5 China Based Human Gene Therapy Manufacturers and Market Share
        4.5.1 China Based Human Gene Therapy Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Human Gene Therapy Production Value (2018-2023)
        4.5.3 China Based Manufacturers Human Gene Therapy Production (2018-2023)
    4.6 Rest of World Based Human Gene Therapy Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Human Gene Therapy Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Human Gene Therapy Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Human Gene Therapy Production (2018-2023)

5 Market Analysis by Type
    5.1 World Human Gene Therapy Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Non-viral Vectors
        5.2.2 Viral Vectors
    5.3 Market Segment by Type
        5.3.1 World Human Gene Therapy Production by Type (2018-2029)
        5.3.2 World Human Gene Therapy Production Value by Type (2018-2029)
        5.3.3 World Human Gene Therapy Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Human Gene Therapy Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Neurological Diseases
        6.2.2 Cancer
        6.2.3 DMD (Duchenne Muscular Dystrophy)
        6.2.4 Hepatological Diseases
        6.2.5 Others
    6.3 Market Segment by Application
        6.3.1 World Human Gene Therapy Production by Application (2018-2029)
        6.3.2 World Human Gene Therapy Production Value by Application (2018-2029)
        6.3.3 World Human Gene Therapy Average Price by Application (2018-2029)

7 Company Profiles
    7.1 Biogen
        7.1.1 Biogen Details
        7.1.2 Biogen Major Business
        7.1.3 Biogen Human Gene Therapy Product and Services
        7.1.4 Biogen Human Gene Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 Biogen Recent Developments/Updates
        7.1.6 Biogen Competitive Strengths & Weaknesses
    7.2 Sarepta Therapeutics
        7.2.1 Sarepta Therapeutics Details
        7.2.2 Sarepta Therapeutics Major Business
        7.2.3 Sarepta Therapeutics Human Gene Therapy Product and Services
        7.2.4 Sarepta Therapeutics Human Gene Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 Sarepta Therapeutics Recent Developments/Updates
        7.2.6 Sarepta Therapeutics Competitive Strengths & Weaknesses
    7.3 Gilead Sciences
        7.3.1 Gilead Sciences Details
        7.3.2 Gilead Sciences Major Business
        7.3.3 Gilead Sciences Human Gene Therapy Product and Services
        7.3.4 Gilead Sciences Human Gene Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 Gilead Sciences Recent Developments/Updates
        7.3.6 Gilead Sciences Competitive Strengths & Weaknesses
    7.4 Amgen
        7.4.1 Amgen Details
        7.4.2 Amgen Major Business
        7.4.3 Amgen Human Gene Therapy Product and Services
        7.4.4 Amgen Human Gene Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 Amgen Recent Developments/Updates
        7.4.6 Amgen Competitive Strengths & Weaknesses
    7.5 Novartis
        7.5.1 Novartis Details
        7.5.2 Novartis Major Business
        7.5.3 Novartis Human Gene Therapy Product and Services
        7.5.4 Novartis Human Gene Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 Novartis Recent Developments/Updates
        7.5.6 Novartis Competitive Strengths & Weaknesses
    7.6 Orchard Therapeutics
        7.6.1 Orchard Therapeutics Details
        7.6.2 Orchard Therapeutics Major Business
        7.6.3 Orchard Therapeutics Human Gene Therapy Product and Services
        7.6.4 Orchard Therapeutics Human Gene Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 Orchard Therapeutics Recent Developments/Updates
        7.6.6 Orchard Therapeutics Competitive Strengths & Weaknesses
    7.7 Spark Therapeutics
        7.7.1 Spark Therapeutics Details
        7.7.2 Spark Therapeutics Major Business
        7.7.3 Spark Therapeutics Human Gene Therapy Product and Services
        7.7.4 Spark Therapeutics Human Gene Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 Spark Therapeutics Recent Developments/Updates
        7.7.6 Spark Therapeutics Competitive Strengths & Weaknesses
    7.8 Agc Biologics
        7.8.1 Agc Biologics Details
        7.8.2 Agc Biologics Major Business
        7.8.3 Agc Biologics Human Gene Therapy Product and Services
        7.8.4 Agc Biologics Human Gene Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 Agc Biologics Recent Developments/Updates
        7.8.6 Agc Biologics Competitive Strengths & Weaknesses
    7.9 Anges
        7.9.1 Anges Details
        7.9.2 Anges Major Business
        7.9.3 Anges Human Gene Therapy Product and Services
        7.9.4 Anges Human Gene Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.9.5 Anges Recent Developments/Updates
        7.9.6 Anges Competitive Strengths & Weaknesses
    7.10 Bluebird Bio
        7.10.1 Bluebird Bio Details
        7.10.2 Bluebird Bio Major Business
        7.10.3 Bluebird Bio Human Gene Therapy Product and Services
        7.10.4 Bluebird Bio Human Gene Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.10.5 Bluebird Bio Recent Developments/Updates
        7.10.6 Bluebird Bio Competitive Strengths & Weaknesses
    7.11 Jazz Pharmaceuticals
        7.11.1 Jazz Pharmaceuticals Details
        7.11.2 Jazz Pharmaceuticals Major Business
        7.11.3 Jazz Pharmaceuticals Human Gene Therapy Product and Services
        7.11.4 Jazz Pharmaceuticals Human Gene Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.11.5 Jazz Pharmaceuticals Recent Developments/Updates
        7.11.6 Jazz Pharmaceuticals Competitive Strengths & Weaknesses
    7.12 Dynavax Technologies
        7.12.1 Dynavax Technologies Details
        7.12.2 Dynavax Technologies Major Business
        7.12.3 Dynavax Technologies Human Gene Therapy Product and Services
        7.12.4 Dynavax Technologies Human Gene Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.12.5 Dynavax Technologies Recent Developments/Updates
        7.12.6 Dynavax Technologies Competitive Strengths & Weaknesses
    7.13 Human Stem Cells Institute
        7.13.1 Human Stem Cells Institute Details
        7.13.2 Human Stem Cells Institute Major Business
        7.13.3 Human Stem Cells Institute Human Gene Therapy Product and Services
        7.13.4 Human Stem Cells Institute Human Gene Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.13.5 Human Stem Cells Institute Recent Developments/Updates
        7.13.6 Human Stem Cells Institute Competitive Strengths & Weaknesses
    7.14 Sibiono Genetech
        7.14.1 Sibiono Genetech Details
        7.14.2 Sibiono Genetech Major Business
        7.14.3 Sibiono Genetech Human Gene Therapy Product and Services
        7.14.4 Sibiono Genetech Human Gene Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.14.5 Sibiono Genetech Recent Developments/Updates
        7.14.6 Sibiono Genetech Competitive Strengths & Weaknesses
    7.15 Shanghai Sunway Biotech
        7.15.1 Shanghai Sunway Biotech Details
        7.15.2 Shanghai Sunway Biotech Major Business
        7.15.3 Shanghai Sunway Biotech Human Gene Therapy Product and Services
        7.15.4 Shanghai Sunway Biotech Human Gene Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.15.5 Shanghai Sunway Biotech Recent Developments/Updates
        7.15.6 Shanghai Sunway Biotech Competitive Strengths & Weaknesses
    7.16 Uniqure N.V.
        7.16.1 Uniqure N.V. Details
        7.16.2 Uniqure N.V. Major Business
        7.16.3 Uniqure N.V. Human Gene Therapy Product and Services
        7.16.4 Uniqure N.V. Human Gene Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.16.5 Uniqure N.V. Recent Developments/Updates
        7.16.6 Uniqure N.V. Competitive Strengths & Weaknesses
    7.17 Gensight Biologics S.A.
        7.17.1 Gensight Biologics S.A. Details
        7.17.2 Gensight Biologics S.A. Major Business
        7.17.3 Gensight Biologics S.A. Human Gene Therapy Product and Services
        7.17.4 Gensight Biologics S.A. Human Gene Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.17.5 Gensight Biologics S.A. Recent Developments/Updates
        7.17.6 Gensight Biologics S.A. Competitive Strengths & Weaknesses
    7.18 Celgene Corporation
        7.18.1 Celgene Corporation Details
        7.18.2 Celgene Corporation Major Business
        7.18.3 Celgene Corporation Human Gene Therapy Product and Services
        7.18.4 Celgene Corporation Human Gene Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.18.5 Celgene Corporation Recent Developments/Updates
        7.18.6 Celgene Corporation Competitive Strengths & Weaknesses
    7.19 Cellectis
        7.19.1 Cellectis Details
        7.19.2 Cellectis Major Business
        7.19.3 Cellectis Human Gene Therapy Product and Services
        7.19.4 Cellectis Human Gene Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.19.5 Cellectis Recent Developments/Updates
        7.19.6 Cellectis Competitive Strengths & Weaknesses
    7.20 Sangamo Therapeutics
        7.20.1 Sangamo Therapeutics Details
        7.20.2 Sangamo Therapeutics Major Business
        7.20.3 Sangamo Therapeutics Human Gene Therapy Product and Services
        7.20.4 Sangamo Therapeutics Human Gene Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.20.5 Sangamo Therapeutics Recent Developments/Updates
        7.20.6 Sangamo Therapeutics Competitive Strengths & Weaknesses
    7.21 Mustang Bio
        7.21.1 Mustang Bio Details
        7.21.2 Mustang Bio Major Business
        7.21.3 Mustang Bio Human Gene Therapy Product and Services
        7.21.4 Mustang Bio Human Gene Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.21.5 Mustang Bio Recent Developments/Updates
        7.21.6 Mustang Bio Competitive Strengths & Weaknesses
    7.22 AGTC
        7.22.1 AGTC Details
        7.22.2 AGTC Major Business
        7.22.3 AGTC Human Gene Therapy Product and Services
        7.22.4 AGTC Human Gene Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.22.5 AGTC Recent Developments/Updates
        7.22.6 AGTC Competitive Strengths & Weaknesses
    7.23 Poseida Therapeutics
        7.23.1 Poseida Therapeutics Details
        7.23.2 Poseida Therapeutics Major Business
        7.23.3 Poseida Therapeutics Human Gene Therapy Product and Services
        7.23.4 Poseida Therapeutics Human Gene Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.23.5 Poseida Therapeutics Recent Developments/Updates
        7.23.6 Poseida Therapeutics Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Human Gene Therapy Industry Chain
    8.2 Human Gene Therapy Upstream Analysis
        8.2.1 Human Gene Therapy Core Raw Materials
        8.2.2 Main Manufacturers of Human Gene Therapy Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Human Gene Therapy Production Mode
    8.6 Human Gene Therapy Procurement Model
    8.7 Human Gene Therapy Industry Sales Model and Sales Channels
        8.7.1 Human Gene Therapy Sales Model
        8.7.2 Human Gene Therapy Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Human Gene Therapy Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Human Gene Therapy Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Human Gene Therapy Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Human Gene Therapy Production Value Market Share by Region (2018-2023)
    Table 5. World Human Gene Therapy Production Value Market Share by Region (2024-2029)
    Table 6. World Human Gene Therapy Production by Region (2018-2023) & (K Units)
    Table 7. World Human Gene Therapy Production by Region (2024-2029) & (K Units)
    Table 8. World Human Gene Therapy Production Market Share by Region (2018-2023)
    Table 9. World Human Gene Therapy Production Market Share by Region (2024-2029)
    Table 10. World Human Gene Therapy Average Price by Region (2018-2023) & (US$/Unit)
    Table 11. World Human Gene Therapy Average Price by Region (2024-2029) & (US$/Unit)
    Table 12. Human Gene Therapy Major Market Trends
    Table 13. World Human Gene Therapy Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
    Table 14. World Human Gene Therapy Consumption by Region (2018-2023) & (K Units)
    Table 15. World Human Gene Therapy Consumption Forecast by Region (2024-2029) & (K Units)
    Table 16. World Human Gene Therapy Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Human Gene Therapy Producers in 2022
    Table 18. World Human Gene Therapy Production by Manufacturer (2018-2023) & (K Units)
    Table 19. Production Market Share of Key Human Gene Therapy Producers in 2022
    Table 20. World Human Gene Therapy Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 21. Global Human Gene Therapy Company Evaluation Quadrant
    Table 22. World Human Gene Therapy Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Human Gene Therapy Production Site of Key Manufacturer
    Table 24. Human Gene Therapy Market: Company Product Type Footprint
    Table 25. Human Gene Therapy Market: Company Product Application Footprint
    Table 26. Human Gene Therapy Competitive Factors
    Table 27. Human Gene Therapy New Entrant and Capacity Expansion Plans
    Table 28. Human Gene Therapy Mergers & Acquisitions Activity
    Table 29. United States VS China Human Gene Therapy Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Human Gene Therapy Production Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 31. United States VS China Human Gene Therapy Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 32. United States Based Human Gene Therapy Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Human Gene Therapy Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Human Gene Therapy Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Human Gene Therapy Production (2018-2023) & (K Units)
    Table 36. United States Based Manufacturers Human Gene Therapy Production Market Share (2018-2023)
    Table 37. China Based Human Gene Therapy Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Human Gene Therapy Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Human Gene Therapy Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Human Gene Therapy Production (2018-2023) & (K Units)
    Table 41. China Based Manufacturers Human Gene Therapy Production Market Share (2018-2023)
    Table 42. Rest of World Based Human Gene Therapy Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Human Gene Therapy Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Human Gene Therapy Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Human Gene Therapy Production (2018-2023) & (K Units)
    Table 46. Rest of World Based Manufacturers Human Gene Therapy Production Market Share (2018-2023)
    Table 47. World Human Gene Therapy Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Human Gene Therapy Production by Type (2018-2023) & (K Units)
    Table 49. World Human Gene Therapy Production by Type (2024-2029) & (K Units)
    Table 50. World Human Gene Therapy Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Human Gene Therapy Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Human Gene Therapy Average Price by Type (2018-2023) & (US$/Unit)
    Table 53. World Human Gene Therapy Average Price by Type (2024-2029) & (US$/Unit)
    Table 54. World Human Gene Therapy Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Human Gene Therapy Production by Application (2018-2023) & (K Units)
    Table 56. World Human Gene Therapy Production by Application (2024-2029) & (K Units)
    Table 57. World Human Gene Therapy Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Human Gene Therapy Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Human Gene Therapy Average Price by Application (2018-2023) & (US$/Unit)
    Table 60. World Human Gene Therapy Average Price by Application (2024-2029) & (US$/Unit)
    Table 61. Biogen Basic Information, Manufacturing Base and Competitors
    Table 62. Biogen Major Business
    Table 63. Biogen Human Gene Therapy Product and Services
    Table 64. Biogen Human Gene Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. Biogen Recent Developments/Updates
    Table 66. Biogen Competitive Strengths & Weaknesses
    Table 67. Sarepta Therapeutics Basic Information, Manufacturing Base and Competitors
    Table 68. Sarepta Therapeutics Major Business
    Table 69. Sarepta Therapeutics Human Gene Therapy Product and Services
    Table 70. Sarepta Therapeutics Human Gene Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. Sarepta Therapeutics Recent Developments/Updates
    Table 72. Sarepta Therapeutics Competitive Strengths & Weaknesses
    Table 73. Gilead Sciences Basic Information, Manufacturing Base and Competitors
    Table 74. Gilead Sciences Major Business
    Table 75. Gilead Sciences Human Gene Therapy Product and Services
    Table 76. Gilead Sciences Human Gene Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Gilead Sciences Recent Developments/Updates
    Table 78. Gilead Sciences Competitive Strengths & Weaknesses
    Table 79. Amgen Basic Information, Manufacturing Base and Competitors
    Table 80. Amgen Major Business
    Table 81. Amgen Human Gene Therapy Product and Services
    Table 82. Amgen Human Gene Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. Amgen Recent Developments/Updates
    Table 84. Amgen Competitive Strengths & Weaknesses
    Table 85. Novartis Basic Information, Manufacturing Base and Competitors
    Table 86. Novartis Major Business
    Table 87. Novartis Human Gene Therapy Product and Services
    Table 88. Novartis Human Gene Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. Novartis Recent Developments/Updates
    Table 90. Novartis Competitive Strengths & Weaknesses
    Table 91. Orchard Therapeutics Basic Information, Manufacturing Base and Competitors
    Table 92. Orchard Therapeutics Major Business
    Table 93. Orchard Therapeutics Human Gene Therapy Product and Services
    Table 94. Orchard Therapeutics Human Gene Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. Orchard Therapeutics Recent Developments/Updates
    Table 96. Orchard Therapeutics Competitive Strengths & Weaknesses
    Table 97. Spark Therapeutics Basic Information, Manufacturing Base and Competitors
    Table 98. Spark Therapeutics Major Business
    Table 99. Spark Therapeutics Human Gene Therapy Product and Services
    Table 100. Spark Therapeutics Human Gene Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. Spark Therapeutics Recent Developments/Updates
    Table 102. Spark Therapeutics Competitive Strengths & Weaknesses
    Table 103. Agc Biologics Basic Information, Manufacturing Base and Competitors
    Table 104. Agc Biologics Major Business
    Table 105. Agc Biologics Human Gene Therapy Product and Services
    Table 106. Agc Biologics Human Gene Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 107. Agc Biologics Recent Developments/Updates
    Table 108. Agc Biologics Competitive Strengths & Weaknesses
    Table 109. Anges Basic Information, Manufacturing Base and Competitors
    Table 110. Anges Major Business
    Table 111. Anges Human Gene Therapy Product and Services
    Table 112. Anges Human Gene Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 113. Anges Recent Developments/Updates
    Table 114. Anges Competitive Strengths & Weaknesses
    Table 115. Bluebird Bio Basic Information, Manufacturing Base and Competitors
    Table 116. Bluebird Bio Major Business
    Table 117. Bluebird Bio Human Gene Therapy Product and Services
    Table 118. Bluebird Bio Human Gene Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 119. Bluebird Bio Recent Developments/Updates
    Table 120. Bluebird Bio Competitive Strengths & Weaknesses
    Table 121. Jazz Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 122. Jazz Pharmaceuticals Major Business
    Table 123. Jazz Pharmaceuticals Human Gene Therapy Product and Services
    Table 124. Jazz Pharmaceuticals Human Gene Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 125. Jazz Pharmaceuticals Recent Developments/Updates
    Table 126. Jazz Pharmaceuticals Competitive Strengths & Weaknesses
    Table 127. Dynavax Technologies Basic Information, Manufacturing Base and Competitors
    Table 128. Dynavax Technologies Major Business
    Table 129. Dynavax Technologies Human Gene Therapy Product and Services
    Table 130. Dynavax Technologies Human Gene Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 131. Dynavax Technologies Recent Developments/Updates
    Table 132. Dynavax Technologies Competitive Strengths & Weaknesses
    Table 133. Human Stem Cells Institute Basic Information, Manufacturing Base and Competitors
    Table 134. Human Stem Cells Institute Major Business
    Table 135. Human Stem Cells Institute Human Gene Therapy Product and Services
    Table 136. Human Stem Cells Institute Human Gene Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 137. Human Stem Cells Institute Recent Developments/Updates
    Table 138. Human Stem Cells Institute Competitive Strengths & Weaknesses
    Table 139. Sibiono Genetech Basic Information, Manufacturing Base and Competitors
    Table 140. Sibiono Genetech Major Business
    Table 141. Sibiono Genetech Human Gene Therapy Product and Services
    Table 142. Sibiono Genetech Human Gene Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 143. Sibiono Genetech Recent Developments/Updates
    Table 144. Sibiono Genetech Competitive Strengths & Weaknesses
    Table 145. Shanghai Sunway Biotech Basic Information, Manufacturing Base and Competitors
    Table 146. Shanghai Sunway Biotech Major Business
    Table 147. Shanghai Sunway Biotech Human Gene Therapy Product and Services
    Table 148. Shanghai Sunway Biotech Human Gene Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 149. Shanghai Sunway Biotech Recent Developments/Updates
    Table 150. Shanghai Sunway Biotech Competitive Strengths & Weaknesses
    Table 151. Uniqure N.V. Basic Information, Manufacturing Base and Competitors
    Table 152. Uniqure N.V. Major Business
    Table 153. Uniqure N.V. Human Gene Therapy Product and Services
    Table 154. Uniqure N.V. Human Gene Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 155. Uniqure N.V. Recent Developments/Updates
    Table 156. Uniqure N.V. Competitive Strengths & Weaknesses
    Table 157. Gensight Biologics S.A. Basic Information, Manufacturing Base and Competitors
    Table 158. Gensight Biologics S.A. Major Business
    Table 159. Gensight Biologics S.A. Human Gene Therapy Product and Services
    Table 160. Gensight Biologics S.A. Human Gene Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 161. Gensight Biologics S.A. Recent Developments/Updates
    Table 162. Gensight Biologics S.A. Competitive Strengths & Weaknesses
    Table 163. Celgene Corporation Basic Information, Manufacturing Base and Competitors
    Table 164. Celgene Corporation Major Business
    Table 165. Celgene Corporation Human Gene Therapy Product and Services
    Table 166. Celgene Corporation Human Gene Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 167. Celgene Corporation Recent Developments/Updates
    Table 168. Celgene Corporation Competitive Strengths & Weaknesses
    Table 169. Cellectis Basic Information, Manufacturing Base and Competitors
    Table 170. Cellectis Major Business
    Table 171. Cellectis Human Gene Therapy Product and Services
    Table 172. Cellectis Human Gene Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 173. Cellectis Recent Developments/Updates
    Table 174. Cellectis Competitive Strengths & Weaknesses
    Table 175. Sangamo Therapeutics Basic Information, Manufacturing Base and Competitors
    Table 176. Sangamo Therapeutics Major Business
    Table 177. Sangamo Therapeutics Human Gene Therapy Product and Services
    Table 178. Sangamo Therapeutics Human Gene Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 179. Sangamo Therapeutics Recent Developments/Updates
    Table 180. Sangamo Therapeutics Competitive Strengths & Weaknesses
    Table 181. Mustang Bio Basic Information, Manufacturing Base and Competitors
    Table 182. Mustang Bio Major Business
    Table 183. Mustang Bio Human Gene Therapy Product and Services
    Table 184. Mustang Bio Human Gene Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 185. Mustang Bio Recent Developments/Updates
    Table 186. Mustang Bio Competitive Strengths & Weaknesses
    Table 187. AGTC Basic Information, Manufacturing Base and Competitors
    Table 188. AGTC Major Business
    Table 189. AGTC Human Gene Therapy Product and Services
    Table 190. AGTC Human Gene Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 191. AGTC Recent Developments/Updates
    Table 192. Poseida Therapeutics Basic Information, Manufacturing Base and Competitors
    Table 193. Poseida Therapeutics Major Business
    Table 194. Poseida Therapeutics Human Gene Therapy Product and Services
    Table 195. Poseida Therapeutics Human Gene Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 196. Global Key Players of Human Gene Therapy Upstream (Raw Materials)
    Table 197. Human Gene Therapy Typical Customers
    Table 198. Human Gene Therapy Typical Distributors
List of Figure
    Figure 1. Human Gene Therapy Picture
    Figure 2. World Human Gene Therapy Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Human Gene Therapy Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Human Gene Therapy Production (2018-2029) & (K Units)
    Figure 5. World Human Gene Therapy Average Price (2018-2029) & (US$/Unit)
    Figure 6. World Human Gene Therapy Production Value Market Share by Region (2018-2029)
    Figure 7. World Human Gene Therapy Production Market Share by Region (2018-2029)
    Figure 8. North America Human Gene Therapy Production (2018-2029) & (K Units)
    Figure 9. Europe Human Gene Therapy Production (2018-2029) & (K Units)
    Figure 10. China Human Gene Therapy Production (2018-2029) & (K Units)
    Figure 11. Japan Human Gene Therapy Production (2018-2029) & (K Units)
    Figure 12. Human Gene Therapy Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Human Gene Therapy Consumption (2018-2029) & (K Units)
    Figure 15. World Human Gene Therapy Consumption Market Share by Region (2018-2029)
    Figure 16. United States Human Gene Therapy Consumption (2018-2029) & (K Units)
    Figure 17. China Human Gene Therapy Consumption (2018-2029) & (K Units)
    Figure 18. Europe Human Gene Therapy Consumption (2018-2029) & (K Units)
    Figure 19. Japan Human Gene Therapy Consumption (2018-2029) & (K Units)
    Figure 20. South Korea Human Gene Therapy Consumption (2018-2029) & (K Units)
    Figure 21. ASEAN Human Gene Therapy Consumption (2018-2029) & (K Units)
    Figure 22. India Human Gene Therapy Consumption (2018-2029) & (K Units)
    Figure 23. Producer Shipments of Human Gene Therapy by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Human Gene Therapy Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Human Gene Therapy Markets in 2022
    Figure 26. United States VS China: Human Gene Therapy Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Human Gene Therapy Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Human Gene Therapy Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Human Gene Therapy Production Market Share 2022
    Figure 30. China Based Manufacturers Human Gene Therapy Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Human Gene Therapy Production Market Share 2022
    Figure 32. World Human Gene Therapy Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Human Gene Therapy Production Value Market Share by Type in 2022
    Figure 34. Non-viral Vectors
    Figure 35. Viral Vectors
    Figure 36. World Human Gene Therapy Production Market Share by Type (2018-2029)
    Figure 37. World Human Gene Therapy Production Value Market Share by Type (2018-2029)
    Figure 38. World Human Gene Therapy Average Price by Type (2018-2029) & (US$/Unit)
    Figure 39. World Human Gene Therapy Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 40. World Human Gene Therapy Production Value Market Share by Application in 2022
    Figure 41. Neurological Diseases
    Figure 42. Cancer
    Figure 43. DMD (Duchenne Muscular Dystrophy)
    Figure 44. Hepatological Diseases
    Figure 45. Others
    Figure 46. World Human Gene Therapy Production Market Share by Application (2018-2029)
    Figure 47. World Human Gene Therapy Production Value Market Share by Application (2018-2029)
    Figure 48. World Human Gene Therapy Average Price by Application (2018-2029) & (US$/Unit)
    Figure 49. Human Gene Therapy Industry Chain
    Figure 50. Human Gene Therapy Procurement Model
    Figure 51. Human Gene Therapy Sales Model
    Figure 52. Human Gene Therapy Sales Channels, Direct Sales, and Distribution
    Figure 53. Methodology
    Figure 54. Research Process and Data Source

Companies Mentioned

Biogen
Sarepta Therapeutics
Gilead Sciences
Amgen
Novartis
Orchard Therapeutics
Spark Therapeutics
Agc Biologics
Anges
Bluebird Bio
Jazz Pharmaceuticals
Dynavax Technologies
Human Stem Cells Institute
Sibiono Genetech
Shanghai Sunway Biotech
Uniqure N.V.
Gensight Biologics S.A.
Celgene Corporation
Cellectis
Sangamo Therapeutics
Mustang Bio
AGTC
Poseida Therapeutics